These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18451298)

  • 1. Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.
    Wender PA; Kee JM; Warrington JM
    Science; 2008 May; 320(5876):649-52. PubMed ID: 18451298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.
    Márquez N; Calzado MA; Sánchez-Duffhues G; Pérez M; Minassi A; Pagani A; Appendino G; Diaz L; Muñoz-Fernández MA; Muñoz E
    Biochem Pharmacol; 2008 Mar; 75(6):1370-80. PubMed ID: 18241838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
    De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
    Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
    Hezareh M
    Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.
    Kulkosky J; Culnan DM; Roman J; Dornadula G; Schnell M; Boyd MR; Pomerantz RJ
    Blood; 2001 Nov; 98(10):3006-15. PubMed ID: 11698284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate.
    Bocklandt S; Blumberg PM; Hamer DH
    Antiviral Res; 2003 Jul; 59(2):89-98. PubMed ID: 12895692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Wender PA; Hardman CT; Ho S; Jeffreys MS; Maclaren JK; Quiroz RV; Ryckbosch SM; Shimizu AJ; Sloane JL; Stevens MC
    Science; 2017 Oct; 358(6360):218-223. PubMed ID: 29026042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostratin: An Overview.
    Miana GA; Riaz M; Shahzad-ul-Hussan S; Paracha RZ; Paracha UZ
    Mini Rev Med Chem; 2015; 15(13):1122-30. PubMed ID: 25963564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Croton megalobotrys Müll Arg. traditional medicine in HIV/AIDS management: Documentation of patient use, in vitro activation of latent HIV-1 provirus, and isolation of active phorbol esters.
    Tietjen I; Ngwenya BN; Fotso G; Williams DE; Simonambango S; Ngadjui BT; Andersen RJ; Brockman MA; Brumme ZL; Andrae-Marobela K
    J Ethnopharmacol; 2018 Jan; 211():267-277. PubMed ID: 28970153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.
    Sloane JL; Benner NL; Keenan KN; Zang X; Soliman MSA; Wu X; Dimapasoc M; Chun TW; Marsden MD; Zack JA; Wender PA
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10688-10698. PubMed ID: 32371485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.
    Wang C; Yang S; Lu H; You H; Ni M; Shan W; Lin T; Gao X; Chen H; Zhou Q; Xue Y
    PLoS One; 2015; 10(11):e0142739. PubMed ID: 26569506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents.
    Kulkosky J; Sullivan J; Xu Y; Souder E; Hamer DH; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2004 May; 20(5):497-505. PubMed ID: 15186524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products.
    Richard K; Williams DE; de Silva ED; Brockman MA; Brumme ZL; Andersen RJ; Tietjen I
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29954099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostratin antagonizes HIV latency by activating NF-kappaB.
    Williams SA; Chen LF; Kwon H; Fenard D; Bisgrove D; Verdin E; Greene WC
    J Biol Chem; 2004 Oct; 279(40):42008-17. PubMed ID: 15284245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.
    DeChristopher BA; Loy BA; Marsden MD; Schrier AJ; Zack JA; Wender PA
    Nat Chem; 2012 Sep; 4(9):705-10. PubMed ID: 22914190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.
    Gustafson KR; Cardellina JH; McMahon JB; Gulakowski RJ; Ishitoya J; Szallasi Z; Lewin NE; Blumberg PM; Weislow OS; Beutler JA
    J Med Chem; 1992 May; 35(11):1978-86. PubMed ID: 1597853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.
    Lu P; Qu X; Shen Y; Jiang Z; Wang P; Zeng H; Ji H; Deng J; Yang X; Li X; Lu H; Zhu H
    Sci Rep; 2016 Apr; 6():24100. PubMed ID: 27067814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.